(Q40005125)

English

The hematopoietic cell transplantation comorbidity index (HCT-CI) predicts clinical outcomes in lymphoma and myeloma patients after reduced-intensity or non-myeloablative allogeneic stem cell transplantation.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19194465%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

The hematopoietic cell transplantation comorbidity index (HCT-CI) predicts clinical outcomes in lymphoma and myeloma patients after reduced-intensity or non-myeloablative allogeneic stem cell transplantation (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19194465%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

stem cell transplantation

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19194465%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Paolo Corradini

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19194465%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Francesco Spina

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19194465%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

author name string

B Bruno

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19194465%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

F Patriarca

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19194465%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

R Sorasio

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19194465%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

M Morelli

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19194465%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

R Fanin

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19194465%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

M Boccadoro

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19194465%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

language of work or name

1 reference

based on heuristic

inferred from title

publication date

5 February 2009

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19194465%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19194465%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

23

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19194465%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19194465%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

1131-1138

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19194465%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.1

7 January 2021

based on heuristic

inferred from DOI database lookup

Chemoresistant or aggressive lymphoma predicts for a poor outcome following reduced-intensity allogeneic progenitor cell transplantation: an analysis from the Lymphoma Working Party of the European Group for Blood and Bone Marrow Transplantation

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.1

7 January 2021

based on heuristic

inferred from DOI database lookup

Reduced-intensity conditioning for allogeneic haematopoietic stem cell transplantation in relapsed and refractory Hodgkin lymphoma: impact of alemtuzumab and donor lymphocyte infusions on long-term outcomes.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.1

7 January 2021

based on heuristic

inferred from DOI database lookup

Improved outcome of allogeneic transplantation in high-risk multiple myeloma patients after nonmyeloablative conditioning

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.1

7 January 2021

based on heuristic

inferred from DOI database lookup

Unrelated stem cell transplantation in multiple myeloma after a reduced-intensity conditioning with pretransplantation antithymocyte globulin is highly effective with low transplantation-related mortality

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.1

7 January 2021

based on heuristic

inferred from DOI database lookup

Nonmyeloablative allogeneic hematopoietic cell transplantation in relapsed, refractory, and transformed indolent non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.1

7 January 2021

based on heuristic

inferred from DOI database lookup

Outcomes after alemtuzumab-containing reduced-intensity allogeneic transplantation regimen for relapsed and refractory non-Hodgkin lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.1

7 January 2021

based on heuristic

inferred from DOI database lookup

BEAM-alemtuzumab reduced-intensity allogeneic stem cell transplantation for lymphoproliferative diseases: GVHD, toxicity, and survival in 65 patients.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.1

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of age and previous autologous transplantation on nonrelapse mortality and survival in patients treated with reduced-intensity conditioning and allografting for advanced hematologic malignancies

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.1

7 January 2021

based on heuristic

inferred from DOI database lookup

Outcomes for reduced-intensity allogeneic transplantation for multiple myeloma: an analysis of prognostic factors from the Chronic Leukaemia Working Party of the EBMT.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.1

7 January 2021

based on heuristic

inferred from DOI database lookup

Reduced-intensity conditioning compared with conventional allogeneic stem-cell transplantation in relapsed or refractory Hodgkin's lymphoma: an analysis from the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.1

7 January 2021

based on heuristic

inferred from DOI database lookup

Nonmyeloablative allogeneic hematopoietic transplantation: a promising salvage therapy for patients with non-Hodgkin's lymphoma whose disease has failed a prior autologous transplantation

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.1

7 January 2021

based on heuristic

inferred from DOI database lookup

Factors associated with outcomes in allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning after failed myeloablative hematopoietic cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.1

7 January 2021

based on heuristic

inferred from DOI database lookup

Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.1

7 January 2021

based on heuristic

inferred from DOI database lookup

Hematopoietic cell transplantation-comorbidity index and Karnofsky performance status are independent predictors of morbidity and mortality after allogeneic nonmyeloablative hematopoietic cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.1

7 January 2021

based on heuristic

inferred from DOI database lookup

Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.1

7 January 2021

based on heuristic

inferred from DOI database lookup

Use of positron emission tomography for response assessment of lymphoma: consensus of the Imaging Subcommittee of International Harmonization Project in Lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.1

7 January 2021

based on heuristic

inferred from DOI database lookup

International uniform response criteria for multiple myeloma.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.1

7 January 2021

based on heuristic

inferred from DOI database lookup

Outcomes after allogeneic hematopoietic cell transplantation with nonmyeloablative or myeloablative conditioning regimens for treatment of lymphoma and chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.1

7 January 2021

based on heuristic

inferred from DOI database lookup

Impact of comorbidity indexes on non-relapse mortality.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.1

7 January 2021

based on heuristic

inferred from DOI database lookup

Performance status, but not the hematopoietic cell transplantation comorbidity index (HCT-CI), predicts mortality at a Canadian transplant center.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.1

7 January 2021

based on heuristic

inferred from DOI database lookup

Reduced-intensity allogeneic transplant in patients older than 55 years: unrelated umbilical cord blood is safe and effective for patients without a matched related donor

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.1

7 January 2021

based on heuristic

inferred from DOI database lookup

Hematopoietic cell transplantation specific comorbidity index as an outcome predictor for patients with acute myeloid leukemia in first remission: combined FHCRC and MDACC experiences

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.1

7 January 2021

based on heuristic

inferred from DOI database lookup

Chronic GVHD and pretransplantation abnormalities in pulmonary function are the main determinants predicting worsening pulmonary function in long-term survivors after stem cell transplantation.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.1

7 January 2021

based on heuristic

inferred from DOI database lookup

Acute GvHD: pathogenesis and classification

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.1

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/LEU.2009.1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19194465%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19194465%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40005125&oldid=2203312300"